← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3263)
- Expression of HNF4G and its potential functions in lung cancer. (2017/12/04) ♡
- Mistletoe (Viscum album) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells. (2017/12/01) ♡
- Seleno-short-chain chitosan induces apoptosis in human non-small-cell lung cancer A549 cells through ROS-mediated mitochondrial pathway. (2017/12/01) ♡
- Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition. (2017/12/01) ♡
- Exome-wide association study of plasma lipids in >300,000 individuals. (2017/12/01) ♡
- Preoperative Geriatric Nutritional Risk Index: A predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer. (2017/12/01) ♡
- Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer. (2017/12/01) ♡
- Durvalumab for the treatment of urothelial carcinoma. (2017/12/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Knocking down MiR-15a expression promotes the occurrence and development and induces the EMT of NSCLC cells in vitro. (2017/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer. (2017/12/01) ♡
- Functional Role of CyclinD1 Polymorphism (G870A) in Modifying Susceptibility and Overall Survival of North Indian Lung Cancer Patients. (2017/12/01) ♡
- Combined C-reactive protein and Neutrophil to Lymphocyte ratio use predict survival in non-small-cell lung cancer. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of radiation therapy in the management of small cell lung cancer. (2017/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe intestinal ischemia during chemotherapy for small cell lung cancer. (2017/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment for non-small-cell lung cancer and circulating tumor cells. (2017/12/01) ♡
- A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy. (2017/11/29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study. (2017/11/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report. (2017/11/27) ♡
- Expression of TDRD9 in a subset of lung carcinomas by CpG island hypomethylation protects from DNA damage. (2017/11/27) ♡
- Barriers to non-small cell lung cancer trial eligibility. (2017/11/24) ♡
- Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS). (2017/11/24) ♡
- Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells. (2017/11/18) ♡
- Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells. (2017/11/15) ♡
- Involvement of autophagy in the outcome of mitotic catastrophe. (2017/11/06) ♡
- Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy. (2017/11/06) ♡
- Anticancer Effects of a Korean Herbal Medicine Formula (H9) via AMPK and HER2-PI3K/Akt Signaling in Breast Cancer Cells. (2017/11/01) ♡
- Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non-Small Cell Lung Carcinoma. (2017/11/01) ♡
- Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator. (2017/11/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study. (2017/11/01) ♡
- Estrogen metabolism in the human lung: impact of tumorigenesis, smoke, sex and race/ethnicity. (2017/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Symptom Management Strategies for Patients Receiving Anaplastic Lymphoma Kinase Inhibitors for Non-Small Cell Lung Cancer. (2017/11/01) ♡
- Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. (2017/10/31) ♡
- Inhibition of STAT3/VEGF/CDK2 axis signaling is critically involved in the antiangiogenic and apoptotic effects of arsenic herbal mixture PROS in non-small lung cancer cells. (2017/10/19) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo. (2017/10/18) ♡
- Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer. (2017/10/17) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Inflamed actinic keratoses associated with pemetrexed and carboplatin therapy. (2017/10/15) ♡
- Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes. (2017/10/12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study. (2017/10/01) ♡
- Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells. (2017/10/01) ♡
- Molecular Dynamics Validation of Crizotinib Resistance to ALK Mutations (L1196M and G1269A) and Identification of Specific Inhibitors. (2017/10/01) ♡
- Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer. (2017/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Should resistance training be targeted to a specific subgroup of patients with non-small cell lung cancer? - Reply. (2017/10/01) ♡
- Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women. (2017/10/01) ♡
- Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group. (2017/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors. (2017/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Surveillance imaging following definitive radiotherapy for non-small cell lung cancer: What is the clinical impact? (2017/10/01) ♡
- Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive cases. (2017/10/01) ♡
- Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer. (2017/09/18) ♡
- Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis. (2017/09/15) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.